The global endoluminal suturing devices market was worth $45.10 million in 2021 and is expected to reach $88.06 million by 2028, growing at 11.80% CAGR.
The global Endoluminal Suturing Devices market was worth around USD 45.10 million in 2021 and is estimated to grow to about USD 88.06 million by 2028, with a compound annual growth rate (CAGR) of approximately 11.80 percent over the forecast period. The report analyzes the Endoluminal Suturing Devices market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the Endoluminal Suturing Devices market.
Endoscopic suturing devices have shown significant growth in the market demand and are estimated to grow tremendously during the forecast period. A growing number of bariatric surgeries are expected to positively impact the advancement of endoluminal suturing product demand. Industry leaders have been developing novel technologies to meet increasing customer wants and increase their market status, which is likely to propel market development during the forecast period. Doctors use an endoscopic suture device to put full-thickness sutures through a flexible endoscope during advanced endoscopic surgery. This tissue endoscope allows for continuous market expansion. The increased frequency of gastrointestinal abnormalities is due to the development of lifestyle choices, as well as an inappropriate diet and liquor consumption, which will fuel the market growth during the forecast period. Besides, lack of knowledge about the advancement in the technology and skills of the professionals are factors responsible for the growth in the market during the forecast period.
The COVID-19 outbreak negatively impact the growth of the market during the forecast period. The lack of a remedy, the growing number of persons infected with COVID, and the unpredictability about when the crisis will end are far worse than in prior outbreaks. The epidemic has caused region shutdown, border restrictions, and transportation infrastructure breakdowns. Manufacturers are figuring out how to recover from the current circumstances by reorganizing their sales channels and new product introduction.
Increasing cases of chronic diseases will boost the demand
The rise in chronic diseases because of a lifestyle has opened the market for endoluminal suturing. Furthermore, increased rates of several chronic illnesses in the aging population would enhance the market demand for endoluminal suturing devices. Endoscopic suturing equipment for minimally invasive surgery is expected to expand in popularity due to high demand.
The rising cost of devices may hamper the global market growth
The high cost of devices, as well as the additional costs associated with professional maintenance training, are anticipated to limit the market growth. As a result, these realities may constrain the expansion of the global endoluminal suturing devices market.
An increasing number of bariatric surgeries is expected to bring up several growth opportunities
The emerging demand for minimally invasive (MI) bariatric treatments and devices, which reduce the necessity for significant surgeries and result in minimal postoperative stress, will also contribute to the market expansion in the upcoming years. The growing public awareness of health issues, as well as the deployment of robotic technology, are expected to boost the market growth. There has been a substantial growth in the number of cases of weight-related disorders, which is increasing the demand for bariatric surgery.
The global endoluminal suturing devices market is segregated based on type, end-use, and region.
By type, the market is classified into bariatric surgery, gastrointestinal surgery, and gastroesophageal reflux disease surgery. Over the forecast period, the gastrointestinal endoluminal suturing devices market is expected to develop at the fastest rate because of the rising prevalence of chronic disease and the increasing frequency of bariatric procedures Furthermore, increased patient pool and improved healthcare infrastructure are supporting the growth of the market for endoluminal suturing devices.
By end-use, the market is classified into hospitals, ambulatory surgical centers, and others. The hospital segment will dominate the market during the forecast period. The increasing incidence of gastrointestinal ailments and the availability of numerous GI applications such as abdomen-related illnesses will drive the profitability of the sector and fuel the demand for endoluminal suturing devices.
Rising population likely to help North America dominate the global market
North America dominates the global endoluminal suturing devices market because of improved healthcare infrastructure and a huge population susceptible to numerous chronic conditions. Factors such as the presence of significant companies and developed healthcare infrastructure are some of the primary factors responsible for the market's significant share upcoming years.
Also, the increased incidence of operations, injuries, and mental disorders, as well as occupational injuries, are expected to drive the demand. Active lifestyles are also likely to drive market expansion during the forecast period. Rising economies and more medical tourism will also support the market growth over the upcoming years.
Some of the main competitors dominating the global endoluminal suturing devices market include - Apollo Endo-surgery, Inc.; Ethicon Endo-Surgery (Johnson and Johnson); Medtronic Plc.
By Type
By End-Use Outlook
By Region
FrequentlyAsked Questions
Increased rates of several chronic illnesses in the aging population would enhance the market demand for endoluminal suturing devices. Endoscopic suturing equipment for minimally invasive surgery are expected to expand in popularity due to high demand.
According to the report, the global Endoluminal Suturing Devices market was worth about USD 45.10 million in 2021 and is predicted to grow to around USD 88.06 million by 2028, with a compound annual growth rate (CAGR) of around 11.80 percent.
North America dominates the Endoluminal Suturing Devices market and accounts for more than 40 percent of the global revenue due to improved healthcare infrastructure and a huge population susceptible to numerous chronic conditions Factors such as the presence of significant companies and developed healthcare infrastructure are some of the primary factors responsible for the market's significant share upcoming years.
Some of the main competitors dominating the global Endoluminal Suturing Devices market include -Apollo Endosurgery, Inc.; Ethicon Endo-Surgery (Johnson and Johnson); Medtronic Plc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed